{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:46:44Z","timestamp":1771832804984,"version":"3.50.1"},"reference-count":26,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Mechanisms and Methods"],"published-print":{"date-parts":[[2017,6,13]]},"DOI":"10.1080\/15376516.2017.1288768","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T06:08:33Z","timestamp":1485929313000},"page":"352-362","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Toxicity assessment of molindone hydrochloride, a dopamine D2\/D5 receptor antagonist in juvenile and adult rats"],"prefix":"10.1080","volume":"27","author":[{"given":"Gopala","family":"Krishna","sequence":"first","affiliation":[{"name":"Supernus Pharmaceuticals Inc., Rockville, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopa","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Supernus Pharmaceuticals Inc., Rockville, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saryu","family":"Goel","sequence":"additional","affiliation":[{"name":"Supernus Pharmaceuticals Inc., Rockville, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"CIT0001","first-page":"485","volume-title":"Psychosis and mania","author":"Baldessarini R","year":"2001","edition":"10"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2004.03.004"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0017"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-4900(03)00089-3"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000824"},{"key":"CIT0006","unstructured":"Clinicaltrials.Gov. (2011). A study to evaluate the efficacy and safety of molindone hydrochloride XR tablets as adjunctive therapy in children with impulsive aggression comorbid with attention-deficit\/hyperactivity disorder (ADHD). NCT01364662. [Online]. Available from: http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01364662?term=molindone&rank=3 [updated 22 May 2013; last accessed 18 Nov 2015]."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2916"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1177\/0192623312448935"},{"key":"CIT0009","unstructured":"International Conference on Harmonisation (ICH). (2008). Dose selection for carcinogenicity studies of pharmaceuticals: S1C(R2). ICH Harmonised Tripartite Guideline."},{"key":"CIT0010","unstructured":"International Conference on Harmonisation (ICH). (2014). Nonclinical safety testing in support of development of pediatric medicines: S11, Final Concept Paper."},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"SP167","DOI":"10.2131\/jts.34.S167","volume":"34","author":"Izumi Y","year":"2009","journal-title":"J Toxicol Sci"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2015.08.006"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2010.08.001"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1080\/01926230601156260"},{"key":"CIT0015","first-page":"379","volume":"50","author":"Pandurangi AK","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0157-3"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600690120"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08050756"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0087"},{"key":"CIT0020","unstructured":"Supernus Pharmaceuticals Inc. (2014). Supernus received FDA fast track designation for SPN-810. Available at: http:\/\/ir.supernus.com\/releasedetail.cfm?ReleaseID=866208."},{"key":"CIT0021","unstructured":"US FDA. (2005). Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Available at: http:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm078932.pdf [last accessed 19 Sept 2016]."},{"key":"CIT0022","unstructured":"US FDA. (2009). http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/017111s066lbl.pdf. Moban label - Information obtained for New Drug Application (NDA) 017- 111 through Freedom of Information Act. Available at: http:\/\/www.fda.gov\/regulatoryinformation\/foi\/default.htm."},{"key":"CIT0023","unstructured":"US FDA. (2006). Guidance for Industry: Nonclinical Safety Evaluation of Pediatric Drug Products. Available at: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm079247.pdf [last accessed 19 Sept 2016]."},{"key":"CIT0024","first-page":"226","volume":"19","author":"Zamani Z","year":"2015","journal-title":"Iran Biomed J"},{"key":"CIT0025","first-page":"169","volume":"7","author":"Zetin M","year":"1985","journal-title":"Clin Therapeutics"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1177\/0960327114532380"}],"container-title":["Toxicology Mechanisms and Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15376516.2017.1288768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T17:11:28Z","timestamp":1597684288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15376516.2017.1288768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6,13]]}},"alternative-id":["10.1080\/15376516.2017.1288768"],"URL":"https:\/\/doi.org\/10.1080\/15376516.2017.1288768","relation":{},"ISSN":["1537-6516","1537-6524"],"issn-type":[{"value":"1537-6516","type":"print"},{"value":"1537-6524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}